SUN PHARMA /TARO recalls

Recall found. SUN PHARMA /TARO is named in FDA Class II recall D-0848-2026 covering Lidocaine Ointment USP. Hazard: Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH). Identifying details: Lot # AD48154, Exp: 4/30/2027.. Status: Ongoing.

Models with recalls

Lidocaine Ointment USP (1)

All SUN PHARMA /TARO recalls

FDA Class II · Drug · September 23, 2026

Lidocaine Ointment USP recall — SUN PHARMA /TARO

Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).

Official ID D-0848-2026 · Official record ↗

Verify with the official sources:

CPSC — consumer products ↗ (aggregated here)
NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
FDA — food, drugs, medical devices ↗ (aggregated here)
USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
Recalls.gov — the U.S. government’s all-agency portal ↗

Found something wrong or missing? Report a data error.

Compiled from official public-domain government data. Last checked October 22, 2026 at 12:00 PM UTC.